Original Source(s)
Related Content
FDA approves first therapy for Alexander disease
The antisense oligonucleotide reduces production of the abnormal protein that accumulates in supportive cells in the brain.
September 4, 2026
-
2 min
Nasal obstruction may worsen OSA indicators
Increases in apnea-hypopnea events were greatest among patients with an elevated baseline index, while evidence supporting mouth taping remained preliminary.
September 11, 2026
-
4 min
Enterovirus diversity may limit treatment advances
Research highlights expanding diagnostic capabilities but persistent gaps in antiviral therapy and vaccine coverage for pediatric enterovirus infections.
September 8, 2026
-
4 min
